ACVA vs. MEDP, FOUR, HQY, BILI, WPP, LYFT, MARA, SEZL, AMTM, and ETSY
Should you be buying ACV Auctions stock or one of its competitors? The main competitors of ACV Auctions include Medpace (MEDP), Shift4 Payments (FOUR), HealthEquity (HQY), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Marathon Digital (MARA), Sezzle (SEZL), Amentum (AMTM), and Etsy (ETSY). These companies are all part of the "business services" industry.
ACV Auctions vs. Its Competitors
ACV Auctions (NYSE:ACVA) and Medpace (NASDAQ:MEDP) are both mid-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.
Medpace has a consensus target price of $344.82, suggesting a potential upside of 3.46%. Given Medpace's stronger consensus rating and higher probable upside, analysts plainly believe Medpace is more favorable than ACV Auctions.
In the previous week, Medpace had 12 more articles in the media than ACV Auctions. MarketBeat recorded 14 mentions for Medpace and 2 mentions for ACV Auctions. Medpace's average media sentiment score of 0.77 beat ACV Auctions' score of 0.31 indicating that Medpace is being referred to more favorably in the news media.
88.6% of ACV Auctions shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 2.9% of ACV Auctions shares are held by company insiders. Comparatively, 20.3% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
ACV Auctions has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.
Medpace has higher revenue and earnings than ACV Auctions. ACV Auctions is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
Medpace has a net margin of 19.31% compared to ACV Auctions' net margin of -10.98%. Medpace's return on equity of 54.36% beat ACV Auctions' return on equity.
Summary
Medpace beats ACV Auctions on 14 of the 16 factors compared between the two stocks.
Get ACV Auctions News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ACVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ACV Auctions Competitors List
Related Companies and Tools
This page (NYSE:ACVA) was last updated on 7/10/2025 by MarketBeat.com Staff
Free ACVA Stock Alerts